Načítá se...

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?

Systemic lupus erythematosus (SLE) is an autoimmune disease with a complex pathogenesis, which presents a great variability in its presentation and can affect almost all organs and systems. Multiple therapeutic targets have been discovered recently, but there also have been failed attempts to treat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Immunotargets Ther
Hlavní autoři: Lorenzo-Vizcaya, Ana, Fasano, Serena, Isenberg, David A
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7276208/
https://ncbi.nlm.nih.gov/pubmed/32582577
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/ITT.S240874
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!